TAHL CINDY

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
25
Insider Sells Sum
$32.03M

Insider Activity of TAHL CINDY

According to the SEC Form 4 filings, TAHL CINDY, being in a position of

  1. General Counsel and Secretary at Fate Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10874 shares for $47,519,
    over all time since 2017-10-13, has bought 0 shares, and sold 807946 shares for $32.03M.

The largest sale of all time was on 2021-07-01 and amounted to 55534 shares of Fate Therapeutics, Inc. for $4.73M.

Biography of TAHL CINDY

No biography is available at this moment.

2024-01-09SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
10,874
0.0109%
$4.37$47,519-11.33%
2023-11-09SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
24,363
0.0278%
$2.40$58,471+81.31%
2023-01-10SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
11,553
0.0112%
$5.24$60,538-13.57%
2022-06-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
25,000
0.0262%
$22.96$574,000-15.51%
2022-04-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
25,000
0.0243%
$38.85$971,250-47.83%
2022-01-11SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
5,419
0.0057%
$48.53$262,975-43.63%
2022-01-10SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
7,738
0.0076%
$46.43$359,313-45.37%
2022-01-03SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
50,000
0.0511%
$59.34$2.97M-54.33%
2021-10-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
50,000
0.0522%
$58.83$2.94M-41.8%
2021-07-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
55,534
0.0526%
$85.24$4.73M-47.21%
2021-04-01SaleFate Therapeutics, Inc.
FATE
See Remarks
30,000
0.0325%
$83.81$2.51M-23.68%
2021-01-19SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
35,000
0.0376%
$114.76$4.02M-32.99%
2021-01-11SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
3,254
0.0034%
$110.81$360,587-31.03%
2021-01-08SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
6,229
0.0067%
$117.10$729,434-33.06%
2020-11-05SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
38,564
0.0448%
$50.63$1.95M+65.36%
2020-11-04SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
103,038
0.0629%
$26.57$2.74M+65.7%
2020-10-16SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
58,398
0.0364%
$26.49$1.55M+69.92%
2020-10-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
70,000
0.0804%
$40.74$2.85M+103.28%
2020-01-08SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
11,400
0.0142%
$20.72$236,170+51.02%
2019-10-15SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
20,400
0.0261%
$14.24$290,584+95.66%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.